Prompter Scandal Sparks Trading Debate, Bridge Collapse Trial Verdict, Merck Wins FDA Lipfendra Approval, Nadezhdin Convicted Barred, and more...

Prompter Scandal Sparks Trading Debate, Bridge Collapse Trial Verdict, Merck Wins FDA Lipfendra Approval, Nadezhdin Convicted Barred, and more...

July 20, 2026 · 9 min

About this episode

The episode discusses various news topics including a teleprompter scandal, a bridge collapse trial verdict, FDA approval of a new drug, and a political conviction in Russia.

(0:10): White House Teleprompter Scandal: Insider Trading Allegations Spark Regulatory Debate on Prediction Markets (1:45): Morandi Bridge Collapse Trial: Former CEO Sentenced, Victims' Families Seek Justice in Genoa Verdict (3:21): FDA Approves Merck's Lipfendra, First Cholesterol-Lowering Pill, Offering Hope for High-Risk Patients (5:16): Russian Opposition Leader Boris Nadezhdin Convicted, Barred from Parliamentary Race (6:45): EU Court Ruling Limits Platform Immunity, Holds YouTube Liable for Gambling Ad Content To subscribe visit https://www.brief.news . For more updates in your inbox each morning visit www.brief.news . Image credit: Local News Live

More episodes of World News Daily

Explore listener stats, chart rankings, contacts and more on the World News Daily podcast page.